Clinical trial
Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function…
NCT00354042 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00354042 |
|---|---|
| Title | Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Dose Ascending, 4 Period Crossover Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Repeat Inhaled Doses of GW597901X in Asthmatic Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | GW597901X |
| Enrollment | 24 |
| Start date | Aug 1, 2004 |
| First posted | Jul 20, 2006 |
| Last update posted | May 18, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: